| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |